DATA VANTAGE | Super League Triathlon, Hangry, and Udaan in focus

4 min readApr 29, 2025

Edition #463, 24th April 2025

Share You’re reading a redacted version of DealStreetAsia’s DATA VANTAGE twice-weekly newsletter. Unlock the full version and gain exclusive insights by subscribing to DATA VANTAGE today! Reach out to us at subs@dealstreetasia.com to upgrade.

Dear Reader,

Super League Triathlon, the Singapore-based organiser of fast-paced, spectator-friendly triathlon events, has received [redacted] in capital through the issuance of ordinary shares to existing investors RTP Global and Sealyham Investments.

RTP Global, an early-stage investor with main offices in New York, London and Bangalore, had invested $2 million in the company last year.

According to DealStreetAsia DATA VANTAGE, Super League Triathlon had accumulated [redacted] in funding and was valued at [redacted] before the latest allotment.

With the fresh capital injection, the company’s valuation has increased to approximately [redacted], based on our calculations.

The latest fundraising by Super League Triathlon, despite not being a tech-driven company — the usual focus of venture capital — suggests a growing trend in investments beyond tech, including businesses with strong community-building.

The company is still operating at a net loss, and its topline saw a slight decline to $2 million for the 12 months ended January 2024.

Founded by Chris McCormack, CEO Michael D’hulst, and Leonid Boguslavsky, Super League Triathlon (now rebranded to Supertri) organises three types of triathlon races — Supertri League, Supertri E, and By Supertri.

Healthtech funding recovers in Q1 2025

Venture capital funding in Southeast Asia’s healthtech sector showed signs of recovery in the first quarter of 2025, finds DealStreetAsia DATA VANTAGE’s latest report Southeast Asia Deal Review: Q1 2025.

The report highlighted that healthtech startups in the region completed eight deals between January and March 2025, a sharp rebound compared with one transaction sealed in the previous quarter (Q4 2024).

However, in terms of deal value, Q1 2025 was the weakest quarter since 2020, with startups in this category raising only $11 million. The peak was in Q2 2021 — amid the COVID-19 wave — when healthtech startups amassed $524 million.

For the 12 months ended March 31, 2025, Singapore led both deal volume and value in healthtech funding, contributing approximately 65% and 66%, respectively, cementing its spot as the region’s hub for healthtech innovation.

The data further showed that diagnostic tech and curative tech remained strong in Southeast Asia’s healthtech funding in the last 12 months, while telemedicine is no longer a top funding category.

Source: DealStreetAsia’s DATA VANTAGE

The data and information in this newsletter comes from DATA VANTAGE, which tracks regulatory filings to provide you with the latest information on startup fundraising, shareholding and financials. Find out how it can aid you in your decision-making — book a demo today or write to us at subs@dealstreetasia.com

Schedule a free demo session now Executives at top investment firms, financial services majors, and leading private companies use DATA VANTAGE to make smarter investment decisions in Asia. (See how)

Other updates from DATA VANTAGE

Singapore-based fintech startup BetterTradeOff welcomed Achmea Innovation Fund, the corporate venture capital arm of Netherlands-based fintech company Achmea, through the allotment of shares worth [redacted].

Canopy Power, a Singapore-based provider of energy solutions, received a small funding from existing investor [redacted] and new individual investor Maria Belinda Nishball.

Indonesian F&B startup Hangry has allotted preference shares worth [redacted] at varying prices to existing investors, including Orzon Ventures, Alpha Food Ltd., and Rubina Watch Company.

Indian B2B e-commerce unicorn Udaan recently received fresh capital totalling [redacted] through the allotment of preference shares to existing investors Bessemer Venture Partners, Moonstone Investments, and Stanford Endowment.

AI, data science and operations technology company Azendian Solutions has issued both ordinary and preference shares, raising [redacted] from several individual investors, including Singaporean businessman Chin Hwee Tan.

A Message from DealStreetAsia and FT Professional

You’re reading a redacted version of DealStreetAsia’s DATA VANTAGE twice-weekly newsletter. Unlock the full version and gain exclusive insights by subscribing to DATA VANTAGE today! Reach out to us at subs@dealstreetasia.com to upgrade. Anticipate Asia’s Rising Stars and Secure Lucrative Exits

To keep pace with today’s constantly evolving markets, data must be smarter, deeper, and instantly accessible. DATA VANTAGE is our smart, continuously updated research & analytics platform featuring:

  • Key financials, fundraising data, and shareholding information for over 3,000 Asian venture-backed companies registered in Singapore and Indonesia
  • Up to 3 new research reports per month
  • Monthly and quarterly data on private funding in SE Asia, India, and Greater China
  • Twice-weekly DATA VANTAGE premium newsletter
  • Alerts for monitoring companies and sectors
  • 50% discount on tickets to our flagship summit
  • Full access to DealStreetAsia’s premium stories and archives

Combine editorial insights with robust data & research. Gain a competitive edge in the ever-changing private capital investment landscape.

>> Curious? Book a demo now to explore our database!<< © DEALSTREETASIA 2014–2024.

--

--

DealStreetAsia
DealStreetAsia

Written by DealStreetAsia

DealStreetAsia is a Singapore-headquartered, subscription-driven media company, covering all deals — private equity, venture capital & M&As in Asia.

No responses yet